160 related articles for article (PubMed ID: 17634881)
1. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
[TBL] [Abstract][Full Text] [Related]
2. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
Yagyu Y; Awai K; Inoue M; Watai R; Sano T; Hasegawa H; Nishimura Y
AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
[TBL] [Abstract][Full Text] [Related]
3. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
Awai K; Takada K; Onishi H; Hori S
Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
[TBL] [Abstract][Full Text] [Related]
4. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
[TBL] [Abstract][Full Text] [Related]
5. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
[TBL] [Abstract][Full Text] [Related]
6. Multidetector CT with double arterial phase and high-iodine-concentration contrast agent in the detection of hepatocellular carcinoma.
Pozzi Mucelli RM; Como G; Del Frate C; Iuri D; Furlan A; Al-Grhiw E; Bazzocchi M
Radiol Med; 2006 Mar; 111(2):181-91. PubMed ID: 16671376
[TBL] [Abstract][Full Text] [Related]
7. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
[TBL] [Abstract][Full Text] [Related]
8. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
[TBL] [Abstract][Full Text] [Related]
9. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
[TBL] [Abstract][Full Text] [Related]
10. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
[TBL] [Abstract][Full Text] [Related]
11. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
Ma X; Samir AE; Holalkere NS; Sahani DV
AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
[TBL] [Abstract][Full Text] [Related]
12. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
Matoba M; Kitadate M; Kondou T; Yokota H; Tonami H
AJR Am J Roentgenol; 2009 Sep; 193(3):738-44. PubMed ID: 19696287
[TBL] [Abstract][Full Text] [Related]
13. Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
Guerrisi A; Marin D; Nelson RC; De Filippis G; Di Martino M; Barnhart H; Masciangelo R; Guerrisi I; Passariello R; Catalano C
Br J Radiol; 2011 Aug; 84(1004):698-708. PubMed ID: 21750137
[TBL] [Abstract][Full Text] [Related]
14. Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.
Yamaguchi I; Kidoya E; Suzuki M; Kimura H
Radiol Phys Technol; 2011 Jan; 4(1):43-52. PubMed ID: 20872188
[TBL] [Abstract][Full Text] [Related]
15. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
[TBL] [Abstract][Full Text] [Related]
16. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
[TBL] [Abstract][Full Text] [Related]
17. [Optimal phase of dynamic CT for detecting hypervascular hepatocellular carcinoma: evaluation of double arterial phases].
Kajiya Y; Kamimura K; Jinguji M; Nakajo M; Tsuchimochi S; Sako K; Komorizono Y
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):99-104. PubMed ID: 15920968
[TBL] [Abstract][Full Text] [Related]
18. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.
Hori M; Murakami T; Oi H; Kim T; Takahashi S; Matsushita M; Tomoda K; Narumi Y; Kadowaki K; Nakamura H
Acta Radiol; 1998 Mar; 39(2):144-51. PubMed ID: 9529444
[TBL] [Abstract][Full Text] [Related]
20. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
